Conference Coverage
Conference Coverage
Be aware, mindfulness training can lower systolic BP: MB-BP
“This is exactly what we need: a well-done trial with a control group to show that it actually works,” said one expert, cautioning that it...
From the Journals
More weight loss with surgery than new obesity meds: meta-analysis
“This is an exciting period because, 10 years ago, nobody thought that [results with] pharmacotherapy can approach bariatric surgery.”
Guidelines
New ACR vaccination guideline: Take your best shot
Vaccinate patients with rheumatic and musculoskeletal disease against flu and other vaccine-preventable disease whenever possible, experts say.
Conference Coverage
Personalized breast screening a step closer to reality
“Several breast cancer risk prediction models have been created, but we believe this is one of the first models designed to guide breast screening...
Conference Coverage
Novel vaccine approach halts disease after 23 years of breast cancer
“The biggest impact so far for me has been that, for the first time in more than a decade, I am not on any medication. That’s really amazing.”
Conference Coverage
Midodrine may be comparable to albumin for PICD prevention in ACLF
Given the small size of the open-label study, with only 25 patients in each arm, the results should be considered as proof of concept and need to...
Conference Coverage
Balanced crystalloid fluids surpass saline for kidney transplant
Low chloride, balanced-crystalloid IV fluid led to significantly fewer delayed graft function events, compared with saline, in a multicenter trial...
Conference Coverage
Baxdrostat slashes BP in resistant hypertension: BrigHTN
The novel agent lowers aldosterone activity without the off-target inhibition of cortisol synthesis that has thwarted previous drug candidates,...
Conference Coverage
Bepirovirsen: Is a ‘functional cure’ for HBV on the horizon?
“Bepirovirsen is just one RNA-based HBV therapy now being pursued. Several other antisense RNAs as well as the more malleable small interfering...
Conference Coverage
EHR alerts flag acute kidney injury and avert progression
Automated EHR alerts for hospitalized patients alerted clinicians when acute kidney injury developed, triggered stoppage of potentially...
Conference Coverage
Denosumab may halt erosive hand OA progression
In a randomized clinical trial, denosumab seemed to halt progression of erosive hand osteoarthritis, but had a delayed impact on pain.